Table 2.
Compounds | Fr I (%) | Fr I + Et (%) | FrE I + Et (%) | Fr II (%) | Fr II + Et (%) | FrE II + Et (%) |
---|---|---|---|---|---|---|
α-Bisabolol oxide B | 0.35a ± 0.10 | 1.16a ± 0.01 | / | / | / | / |
α-Bisabolol oxide A | 0.33b ± 0.09 | 1.35a ± 0.11 | 0.05b ± 0.02 | / | / | / |
Palmitic acid (C16:0) | 10.80a,b,c ± 0.63 | 11.57a,b ± 0.13 | 11.60a ± 0.08 | 9.80b,c ± 0.32 | 9.25c ± 0.28 | 9.16c ± 0.11 |
Palmitoleic (C16:1) | 0.10a ± 0.01 | 0.60a ± 0.06 | 0.23a ± 0.13 | 0.26a ± 0.16 | 0.52a ± 0.12 | 0.53a ± 0.14 |
Stearic acid (C18:0) | 1.57a ± 0.17 | 1.47a ± 0.48 | 1.51a ± 0.10 | 1.56a ± 0.05 | 1.20a ± 0.06 | 1.19a ± 0.06 |
Oleic acid (C18:1) | 10.72a,b ± 0.17 | 11.75a ± 0.42 | 10.80a,b ± 0.19 | 8.98c ± 0.21 | 8.58c ± 0.16 | 8.70c ± 0.14 |
Elaidic acid (C18:1) | 1.67a ± 0.08 | 2.30a ± 0.20 | 1.95a ± 0.33 | 1.06b ± 0.02 | 1.79a ± 0.15 | 1.78a ± 0.13 |
Linoleic acid (C18:2) | 72.23c,d ± 0.52 | 63.19e ± 1.18 | 69.48d ± 0.46 | 77.58a,b ± 0.05 | 77.83a ± 0.36 | 75.48a,b,c ± 0.29 |
α-Linolenic acid (C18:3) | 0.65a ± 0.11 | 1.35a ± 0.32 | 0.48a ± 0.13 | 0.08b ± 0.03 | t | t |
Arachidonic acid (C20:4) | 0.48a ± 0.20 | 1.10a ± 0.17 | 0.52a ± 0.06 | / | / | / |
Total content | 98.88 ± 1.42 | 95.82 ± 0.33 | 96.60 ± 0.09 | 99.31 ± 0.28 | 99.17 ± 0.82 | 96.83 ± 0.59 |
SFA | 12.37 ± 0.80 | 13.04 ± 0.36 | 13.11 ± 0.02 | 11.36 ± 0.27 | 10.45 ± 0.33 | 10.35 ± 0.17 |
UFA | 85.84 ± 1.10 | 80.28 ± 0.13 | 83.44 ± 0.12 | 87.95 ± 0.01 | 88.72 ± 0.49 | 86.48 ± 0.42 |
PUFA | 73.36 ± 1.42 | 65.63 ± 0.69 | 70.47 ± 0.53 | 77.65 ± 0.02 | 77.83 ± 0.36 | 75.48 ± 0.29 |
SFA saturated fatty acids, PUFA polyunsaturated fatty acid, UFA total unsaturated fatty acids, t found in traces
Different letters in the superscript represent significant differences (p < 0.05) (comparisons were made row-wise)